Effective as of the opening of business on March 20, 2024, Classes A, C and I of the Fund will no longer be closed to new investors and will be available for purchase by all eligible investors.
Objective
Seeks long-term capital appreciation.
Overview
An international stock fund that combines the high active share and low volatility strategies of multiple managers.
The portfolio managers are supported by the full resources of Wellington.
Performance
Performance data quoted represents past performance and does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance data quoted.
SI = Since Inception.
Fund Inception: 06/30/2008
Share Class Inception: 2/28/18.
Class R6-share performance prior to 2/28/18 reflects the performance and operating expenses of Class Y-shares.
Performance for Class R6 shares prior to its inception date would have differed if the operating expenses of Class R6 had been reflected. SI performance is calculated from 6/30/08.
Characteristics
# of Holdings | 460 |
---|---|
% in Equities | 97 |
% in Foreign Equities | 94 |
Beta (3 year) | 1.00 |
R Squared (3 year) | 0.99 |
Standard Deviation | 17.09% |
Turnover- (12/31/2023) | 33% |
Active Share | 63% |
FUND | MSCI ACWI ex USA Index | |
---|---|---|
Price/Earnings | 13.4x | 13.1x |
Price/Book | 1.9x | 1.8x |
EPS Growth Rate | 13.9% | 12.1% |
Asset Weighted Market Cap (billions) | $85.6 | $100.4 |
Return on Equity | 15.9% | 16.3% |
Median Market Cap (billions) | $12.3 | $8.9 |
Japan | 14 |
France | 11 |
United Kingdom | 11 |
China | 6 |
Germany | 6 |
Canada | 5 |
Switzerland | 5 |
Taiwan | 4 |
India | 4 |
South Korea | 4 |
Taiwan Semiconductor Manufacturing Co. Ltd. | 2.72 |
Schneider Electric SE | 1.43 |
Samsung Electronics Co. Ltd. | 1.38 |
AstraZeneca PLC | 1.17 |
Capgemini SE | 1.15 |
Tencent Holdings Ltd. | 1.10 |
Heineken NV | 0.99 |
Airbus SE | 0.98 |
Novartis AG | 0.95 |
ASML Holding NV | 0.91 |
Total Portfolio % | 12.78 |
Less than $2 billion | 4 | |
$2 billion - $5 billion | 5 | |
$5 billion - $10 billion | 8 | |
Greater than $10 billion | 82 | |
Not Classified | 0 |
Alpha (5 Year)
|
-0.04 |
Down Capture (5 Year)
|
101.47 |
Information Ratio (5 Year)
|
-0.02 |
Sharpe Ratio (5 Year)
|
0.26 |
Up Capture (5 Year)
|
100.98 |
FUND |
BENCHMARK | UNDERWEIGHT / OVERWEIGHT | |||||
---|---|---|---|---|---|---|---|
12/31/23 | 2/29/24 | 2/29/24 | -4 0 4 | ||||
Communication Services | 8 | 8 | 5 | ||||
Industrials | 15 | 16 | 14 | ||||
Consumer Discretionary | 14 | 14 | 12 | ||||
Consumer Staples | 10 | 10 | 8 | ||||
Health Care | 10 | 10 | 9 | ||||
Information Technology | 12 | 13 | 13 | ||||
Materials | 6 | 6 | 7 | ||||
Energy | 4 | 4 | 5 | ||||
Real Estate | 1 | 1 | 2 | ||||
Utilities | 1 | 1 | 3 | ||||
Financials | 18 | 17 | 21 |
Insights
Fund Literature